Alseres completes enrollment in phase I/IIa clinical trial of Cethrin and plans phase IIb trial Jan. 10, 2008
New ferritin light chain gene mutant mice, useful to study neuroferritinopathy / News in Context Jan. 9, 2008
Jazz Pharmaceuticals receives orphan drug designation for acute repetitive seizures candidate Jan. 8, 2008
Innocoll initiates dosing in U.S. phase II clinical trial of CollaRx bupivacaine surgical implant Jan. 8, 2008